Notably, CD8+ tumor specific TILs bearing Neo-TCRs display markedly higher avidities and lower strength of peptide recognition as their cognate antigens were at substantially lower concentrations, contrasting the majority of MAA-specific TCRs (Fig. 1b). This evidence concerns the gene CD8A and neoplasm.